Author: Kubitza D Becka M Roth A Mueck W
Publisher: Field House Publishing
ISSN: 0300-0605
Source: The Journal of International Medical Research, Vol.40, Iss.5, 2012-09, pp. : 1688-1707
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Rivaroxaban, the first oral, direct factor Xa inhibitor
Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 18, 2009-12 ,pp. :